Swiss National Bank
MRVI icon

Swiss National Bank’s Maravai LifeSciences MRVI Stock Holding History

Swiss National Bank’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-221,000
Closed -$488K – 2381
2025
Q1 		$488K Hold
221,000
– – ﹤0.01% 2340
2024
Q4 		$1.2M Hold
221,000
– – ﹤0.01% 2117
2024
Q3 		$1.84M Hold
221,000
– – ﹤0.01% 1918
2024
Q2 		$1.58M Hold
221,000
– – ﹤0.01% 1931
2024
Q1 		$1.92M Hold
221,000
– – ﹤0.01% 1861
2023
Q4 		$1.45M Sell
221,000
-25,500
-10% -$165K ﹤0.01% 2034
2023
Q3 		$2.46M Buy
246,500
+2,600
+1% +$28.6K ﹤0.01% 1704
2023
Q2 		$3.03M Buy
243,900
+2,600
+1% +$35.1K ﹤0.01% 1617
2023
Q1 		$3.38M Sell
241,300
-28,700
-11% -$412K ﹤0.01% 1509
2022
Q4 		$3.86M Buy
270,000
+4,900
+2% +$77.2K ﹤0.01% 1469
2022
Q3 		$6.77M Buy
265,100
+2,000
+0.8% +$50.2K ﹤0.01% 1100
2022
Q2 		$7.47M Sell
263,100
-1,100
-0.4% -$34.8K 0.01% 1073
2022
Q1 		$9.32M Buy
264,200
+18,400
+7% +$617K 0.01% 1057
2021
Q4 		$10.3M Sell
245,800
-1,100
-0.4% -$44.6K 0.01% 996
2021
Q3 		$12.1M Buy
246,900
+49,400
+25% +$2.41M 0.01% 899
2021
Q2 		$8.24M Buy
+197,500
New +$7.65M 0.01% 1140

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
PD
Point72 (DIFC) Dubai, United Arab Emirates $1.53B AUM 15.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Swiss National Bank's MRVI Position: Q2 2025 in Review

Swiss National Bank sold out of Maravai LifeSciences (MRVI) in Q2 2025, closing a stake of 221,000 shares — an estimated $488K sold.

Swiss National Bank first reported a position in MRVI in Q2 2021 and held it in 16 quarters. The position peaked at $12.1M in Q3 2021. 150 funds tracked by Wall St. Rank hold MRVI as of Q2 2025.

  • Swiss National Bank reported no remaining Maravai LifeSciences position as of Q2 2025 after selling out during the quarter.
  • Swiss National Bank sold 221,000 Maravai LifeSciences shares in Q2 2025, an estimated $488K.
  • Swiss National Bank first reported a position in Maravai LifeSciences in Q2 2021 and held it in 16 quarters.
  • Swiss National Bank's Maravai LifeSciences position peaked at $12.1M in Q3 2021.
  • 150 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2025.

Based on Swiss National Bank's 13F filing for Q2 2025, filed 12 Aug 2025.